Restenosis after NIR stent implantation

Minerva Cardioangiologica

Volumn 50, Issue 5, 2002, Pages 455-462

  Danzi, G B ^a,b   Sesana, M ^a   Capuano, C ^a   Predolini, S ^a   Baglini, R ^a  

^a Poliambulanza Hospital   (Italy)

^b Casa di Cura Poliambulanza   (Italy)

Author keywords

Angioplasty, transluminal, percutaneous coronary; Graft occlusion, vascular; Restenosis; Stents

Indexed keywords

ANIMAL; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DOG; ELECTROCARDIOGRAPHY; FOLLOW UP; GRAFT OCCLUSION; HUMAN; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; REVIEW; SAFETY; STATISTICAL ANALYSIS; STENT; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; CORONARY RESTENOSIS; DATA INTERPRETATION, STATISTICAL; DOGS; ELECTROCARDIOGRAPHY; FOLLOW-UP STUDIES; GRAFT OCCLUSION, VASCULAR; HUMANS; RANDOMIZED CONTROLLED TRIALS; SAFETY; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0036777743     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Richter K, Almagor Y, Leon MB. The NIR and NIROYAL stents. In: Serruys PW, Kutryk MJB, editors. Handbook of coronary stents. 3rd ed. London UK: Martin Dunitz Ltd; 1998.p.281-94.
2. Serruys PW, Kutryk MJB. Stents: the menu. In: Topol EJ, editor. Textbook of interventional cardiology. Philadelphia: W. B. Saunders; 1999.p.533-85.
3. Almagor Y, Feld S, Kiemeneij F, Serruys PW, Morice MC, Colombo A et al. Predictors of clinical outcome following NIR stent implantation for coronary artery disease: analysis of the results of the first international new intravascular rigid-flex endovascular stent study (FINESS trial). J Interv Cardiol 2002;15:1-6.
4. Danzi GB, Fiocca L, Capuano C, Predolini S, Quaini E. Acute stent recoil: in vivo evaluation of different stent designs. Catheter Cardiovasc Interv 2001;52:147-53.
5. Ormiston JA, Webster MWI, Ruygrok PN, Elliot JM, Simmonds MB, Meredit IT et al. A randomized study of direct coronary stent delivery compared with stenting after predilatation: the NIR future trial. Catheter Cardiovasc Interv 2000;50:377-81; discussion 382-3.
6. Bhargava B, Waksman R, Lansky AJ, Korniowsky R, Mehran R, Leon MB. Clinical outcomes of compromised side branch (stent jail) after coronary stenting with the NIR stent. Catheter Cardiovasc Interv 2001;54:295-300.
7. Baim DS, Cutlip DE, O'Shaugnessy CD, Hermiller JB, Kereiakes DJ, Giambartolomei A et al. Final results of a randomized trial comparing the NIR stent to the Palmaz-Schatz stent for narrowings in native coronary arteries. Am J Cardiol 2001;87:152-6.
8. Rutsch W, Kiemenelj F, Colombo A, Macaya C, Guermonprez JL, Grip L et al. Clinical and angiographic results with the NIR stent: First International NIR Endovascular Stent Study (FINESS-II). Int J Cardiovasc Interv 2000;3:143-51.
9. Eccleshall SC, Jones H, Lichfield M, Jordan PJ, Buller NP, Townend JN. The elective use of the 7-cell NIR stent in coronary arteries <2.75 mm in diameter: clinical and angiographie results at 6-month follow-up. Catheter Cardiovasc Interv 2001;54:174-9.
10. Moer R, Myreng Y, Molstad P, Ytre-Arne K, Sirnes PA, Golf S. Stenting small coronary arteries using 2 second-generation slotted tube stents: acute and 6-month clinical and angiographic results. Catheter Cardiovasc Interv 2000;50:307-13.
11. Kobayashi Y, De Gregorio JD, Kobayashi N, Reimers B, Albiero R, Vaghetti M et al. Comparison of immediate and follow-up results of the short and long NIR stent with the Palmaz-Schatz stent. Am J Cardiol 1999;84:499-504.
12. Serruys PW, Foley DP, Suttorp MJ, Rensing BJWM, Suryapranata H, Materne P et al. A randomized comparison of the value of additional stenting after optimal balloon angioplasty for long coronary lesions: final results of the additional value of NIR stents for treatment of long coronary lesions (ADVANCE) study. J Am Coll Cardiol 2002;39:393-9.
13. Cremonesi A, Benit E, Carlier M, Colombo A, Piva R, Probst P et al. Multicenter registry to evaluate the efficacy of the NIROYAL stent in de novo or restenotic coronary stenosis. J Invas Cardiol 2000;12:225-32.
14. Harding SA, McKenna CJ, Flapan AD, Boon NA. Long-term clinical safety and efficacy of NIROYAL vs NIR intracoronary stent. Catheter Cardiovasc Interv 2001;54: 141-5.
15. Park SJ, Lee CW, Hong MK, Kim JJ, Park SW, Tahk SJ et al. Comparison of gold-coated NIR stents with uncoated NIR stents in patients with coronary artery disease. Am J Cardiol 2002;89:872-5.
16. Danzi GB, Capuano C, Sesana M, Di Blasi A, Predolini S, Antoniucci D. Patterns of in-stent restenosis after placement of NIR gold-coated stents in unselected patients. Catheter Cardiovasc Interv 2002;55:157-62.
17. Reifart N, Morice MC, Silber S, Benit E, Hauptmann KE, de Sousa E et al. The Nugget study NIR ultra gold glided equivalency trial. Circulation submitted.
18. Kastrati A, Schömig A, Dirschinger J, Mehilli J, von Welser N, Pache J et al. Increased risk of restenosis after placement of gold-coated stents: results of a randomized trial comparing gold-coated with uncoated steel stents in patients with coronary artery disease. Circulation 101:2478-83.